Opticrom Allergy Single Dose (Sodium Cromoglicate)

Sodium Cromoglicate, the active ingredient in Opticrom Allergy Single Dose, is a mast cell stabilizer presented as a sterile ophthalmic solution for ocular use. It treats allergic conjunctivitis and ocular allergy in patients who experience eye irritation due to allergens.

GNH USA supplies Opticrom Allergy Single Dose as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Sodium Cromoglicate acts on allergic eye conditions to prevent mast cell degranulation and reduce inflammatory symptoms.

Allergic conjunctivitis: alleviates itching, redness and tearing associated with allergic eye inflammation. Ocular allergy: stabilises mast cells to prevent histamine release and improve comfort. Allergic eye inflammation: reduces swelling and irritation caused by environmental allergens.

Common Side Effects: - Transient burning or stinging sensation after instillation. - Mild eye irritation or foreign‑body feeling. - Temporary blurred vision. - Increased tearing or watery discharge. - Conjunctival hyperemia (redness). - Slight eyelid swelling.

Serious or Rare Side Effects: - Severe ocular pain or photophobia. - Corneal ulceration or epithelial defects. - Vision loss or sudden visual acuity change. - Allergic reaction with swelling of the eyelids or periorbital area. - Anaphylaxis (extremely rare). - Persistent intra‑ocular inflammation.

Before using Opticrom Allergy Single Dose, consider the following precautions: - Pregnancy: consult a healthcare professional before use. - Breastfeeding: safety has not been established; discuss with a physician. - Contact lens wearers: remove lenses before instillation and wait at least 15 minutes before reinserting. - Existing ocular infection: avoid use until infection is resolved. - Avoid contamination: use only the single‑dose unit and discard after opening. - Store at room temperature: keep in the original container, protect from light and moisture.

Sodium Cromoglicate may interact with other ophthalmic agents.

Major Interactions (Avoid): - Concurrent use with ophthalmic anesthetics may increase corneal toxicity. - Co‑administration with other mast cell stabilisers can heighten ocular irritation. - Use with preservative‑rich eye drops may exacerbate stinging.

Moderate Interactions (Monitor Closely): - Combination with topical antihistamines may cause additive burning sensation. - Use with corticosteroid eye drops generally safe but monitor for increased intra‑ocular pressure. - Simultaneous use with contact lens cleaning solutions may cause lens discoloration.